Eterna Therapeutics transfers Nasdaq listing to Capital Market, effective Jan 11, 2023

Ernexa Therapeutics Inc.

Nasdaq Staff approved transfer from Global Market to Capital Market on Jan 9, 2023.
Common stock begins trading on Capital Market at open on Jan 11, 2023 under symbol ERNA.
Company voluntarily applied for transfer on Jan 2, 2023 (previously reported).
Capital Market has similar corporate governance requirements but different financial listing standards.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.